Signaling Pathways
- A8247 Afatinib (BIBW2992)1 CitationTarget: EGFRSummary: Irreversible EGFR/HER2 inhibitor
- A8249 SB 4315422 CitationSummary: ALK inhibitor
- A8250 LY 29400216 CitationTarget: PI3KSummary: Potent PI3K inhibitor
- A8252 Nintedanib (BIBF 1120)3 CitationTarget: VEGFR|PDGFR|FGFRSummary: VEGFR/PDGFR/FGFR inhibitor
- A8253 PD 173074Target: VEGFR|FGFRSummary: FGFR inhibitor
- A8255 Sunitinib malate2 CitationTarget: VEGFRSummary: VEGFR/PDGFRβ/ KIT/ FLT3/RET/CSF-1R inhibitor
- A4604 SP 6001257 CitationTarget: JNKSummary: JNK1/2/3 inhibitor
- A1493 ABT-751 (E7010)1 CitationTarget: Microtubules/TubulinsSummary: Inhibitor of microtubule polymerization,antimitotic
- A2402 FloxuridineTarget: Synthases/SynthetasesSummary: Antineoplastic antimetabolite
- A1832 Doxorubicin (Adriamycin) HCl2 CitationTarget: TopoisomerasesSummary: Antitumour antibiotic,inhibits TOPO II.